Marina Barbosa da SilvaDomênica Baroni Coelho de Oliveira FerreiraCristian D. MendietaH. SilvaLívia Aguiar Nogueira-RosaNathalia Moraes-Figueiredo2026-03-222026-03-22202410.1080/01616412.2024.2440022https://doi.org/10.1080/01616412.2024.2440022https://andeanlibrary.org/handle/123456789/85621Citaciones: 4This meta-analysis suggests that galcanezumab is effective in reducing the number of CH attacks and can be considered a safe medication.enCluster headacheMedicineCalcitonin gene-related peptideMechanism (biology)Cluster (spacecraft)Monoclonal antibodyMeta-analysisPharmacologyBioinformaticsreview